Glen Santangelo
Stock Analyst at Jefferies
(1.87)
# 3,141
Out of 4,918 analysts
76
Total ratings
46.81%
Success rate
-0.39%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Hold | $10 → $8 | $6.94 | +15.27% | 7 | Apr 21, 2025 | |
| ANIP ANI Pharmaceuticals | Initiates: Buy | $80 | $63.89 | +25.22% | 1 | Mar 14, 2025 | |
| VTRS Viatris | Maintains: Buy | $15 → $13 | $8.81 | +47.56% | 4 | Mar 7, 2025 | |
| WAY Waystar Holding | Initiates: Buy | $51 | $35.59 | +43.30% | 1 | Feb 11, 2025 | |
| XERS Xeris Biopharma Holdings | Reiterates: Buy | $4 → $6 | $5.38 | +11.52% | 2 | Jan 29, 2025 | |
| NVST Envista Holdings | Maintains: Hold | $20 → $22 | $20.83 | +5.62% | 1 | Jan 23, 2025 | |
| XRAY DENTSPLY SIRONA | Downgrades: Hold | $30 → $20 | $14.30 | +39.86% | 2 | Jan 23, 2025 | |
| PCRX Pacira BioSciences | Maintains: Buy | $15 → $18 | $22.07 | -18.44% | 5 | Sep 24, 2024 | |
| PGNY Progyny | Maintains: Buy | $31 → $24 | $22.49 | +6.71% | 4 | Sep 19, 2024 | |
| HIMS Hims & Hers Health | Maintains: Hold | $14 → $23 | $62.55 | -63.23% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $23 | $15.38 | +49.54% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $41 → $44 | $30.07 | +46.33% | 3 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $13.79 | +23.28% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $230 | $147.38 | +56.06% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $5.64 | +77.30% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $70 | $21.20 | +230.19% | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $55 | $13.00 | +323.08% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $8.35 | +91.62% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $14 | $5.21 | +168.71% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $46 | $57.33 | -19.76% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $80 | $91.06 | -12.15% | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $3.52 | +695.45% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $26.34 | +165.76% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $7.01 | +1,611.84% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $2 | $2.31 | -13.42% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $4.53 | +937.53% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $3.74 | +862.57% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $62.47 | - | 3 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $173 → $169 | $698.80 | -75.82% | 5 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $156.00 | - | 4 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $79 → $82 | $67.98 | +20.62% | 2 | Apr 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $136.52 | +83.12% | 1 | Dec 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $78 | $11.64 | +570.10% | 1 | Dec 4, 2017 |
Teladoc Health
Apr 21, 2025
Maintains: Hold
Price Target: $10 → $8
Current: $6.94
Upside: +15.27%
ANI Pharmaceuticals
Mar 14, 2025
Initiates: Buy
Price Target: $80
Current: $63.89
Upside: +25.22%
Viatris
Mar 7, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $8.81
Upside: +47.56%
Waystar Holding
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $35.59
Upside: +43.30%
Xeris Biopharma Holdings
Jan 29, 2025
Reiterates: Buy
Price Target: $4 → $6
Current: $5.38
Upside: +11.52%
Envista Holdings
Jan 23, 2025
Maintains: Hold
Price Target: $20 → $22
Current: $20.83
Upside: +5.62%
DENTSPLY SIRONA
Jan 23, 2025
Downgrades: Hold
Price Target: $30 → $20
Current: $14.30
Upside: +39.86%
Pacira BioSciences
Sep 24, 2024
Maintains: Buy
Price Target: $15 → $18
Current: $22.07
Upside: -18.44%
Progyny
Sep 19, 2024
Maintains: Buy
Price Target: $31 → $24
Current: $22.49
Upside: +6.71%
Hims & Hers Health
Jun 27, 2024
Maintains: Hold
Price Target: $14 → $23
Current: $62.55
Upside: -63.23%
Jun 27, 2024
Maintains: Buy
Price Target: $19 → $23
Current: $15.38
Upside: +49.54%
Jun 7, 2024
Upgrades: Buy
Price Target: $41 → $44
Current: $30.07
Upside: +46.33%
Dec 19, 2023
Initiates: Buy
Price Target: $17
Current: $13.79
Upside: +23.28%
Dec 19, 2023
Assumes: Buy
Price Target: $230
Current: $147.38
Upside: +56.06%
Dec 15, 2023
Reiterates: Buy
Price Target: $10
Current: $5.64
Upside: +77.30%
Jul 25, 2023
Reinstates: Buy
Price Target: $70
Current: $21.20
Upside: +230.19%
Oct 21, 2022
Initiates: Hold
Price Target: $55
Current: $13.00
Upside: +323.08%
Oct 21, 2022
Initiates: Buy
Price Target: $16
Current: $8.35
Upside: +91.62%
Oct 21, 2022
Assumes: Buy
Price Target: $14
Current: $5.21
Upside: +168.71%
May 18, 2022
Maintains: Buy
Price Target: $78 → $46
Current: $57.33
Upside: -19.76%
Mar 28, 2022
Maintains: Buy
Price Target: $62 → $80
Current: $91.06
Upside: -12.15%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $3.52
Upside: +695.45%
Dec 2, 2021
Initiates: Buy
Price Target: $70
Current: $26.34
Upside: +165.76%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $7.01
Upside: +1,611.84%
Dec 2, 2021
Initiates: Hold
Price Target: $2
Current: $2.31
Upside: -13.42%
Dec 2, 2021
Initiates: Buy
Price Target: $47
Current: $4.53
Upside: +937.53%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $3.74
Upside: +862.57%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $62.47
Upside: -
May 21, 2020
Maintains: Hold
Price Target: $173 → $169
Current: $698.80
Upside: -75.82%
Dec 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $156.00
Upside: -
Apr 24, 2018
Maintains: Buy
Price Target: $79 → $82
Current: $67.98
Upside: +20.62%
Dec 8, 2017
Initiates: Hold
Price Target: $250
Current: $136.52
Upside: +83.12%
Dec 4, 2017
Initiates: Hold
Price Target: $78
Current: $11.64
Upside: +570.10%